SCHEMBL4928513

SCHEMBL4928513

COc1ccc(Nc2ccc(Cl)cc2N)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.59
GAA P10253 6/20 0.59
MEN1 O00255 4/20 0.59
KMT2A Q03164 4/20 0.59
TDP1 Q9NUW8 4/20 0.59
RAB9A P51151 4/20 0.59
KDM4E B2RXH2 3/20 0.59
ALDH1A1 P00352 3/20 0.59
THRB P10828 2/20 0.59
RECQL P46063 2/20 0.59
HTT P42858 1/20 0.59
MMP14 P50281 1/20 0.59
POLB P06746 2/20 0.54
LMNA P02545 2/20 0.54
NR4A1 P22736 1/20 0.51
MAPK1 P28482 3/20 0.50
L3MBTL1 Q9Y468 3/20 0.50
AKR1C3 P42330 3/20 0.50
AKR1C2 P52895 3/20 0.50
NPC1 O15118 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4933129 0.87 MAPT (0.59) MAPTGAAMEN1KMT2ATDP1
SCHEMBL11750321 0.84 ALDH1A1 (0.48) MAPTGAAMEN1KMT2ATDP1
SCHEMBL5188930 0.83 MAPT (0.57) MAPTGAAMEN1KMT2ATDP1
SCHEMBL4933031 0.82 MAPT (0.57) MAPTGAAMEN1KMT2ATDP1
SCHEMBL31723254 0.81 MAPT (0.53) MAPTGAAMEN1KMT2ATDP1
SCHEMBL22232049 0.81 MAPT (0.53) MAPTGAAMEN1KMT2ATDP1
SCHEMBL24208167 0.81 MAPT (0.64) MAPTGAAMEN1KMT2ATDP1
SCHEMBL4921169 0.81 MEN1 (0.47) MAPTGAAMEN1KMT2ATDP1
SCHEMBL15201407 0.81 MAPT (0.59) MAPTGAAMEN1KMT2ATDP1
SCHEMBL4930961 0.80 CHRNA7 (0.46) MAPTGAAMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080021069-A1 Receptor Function Regulating Agent TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-01-24 US disclosed
US-20080021069-A1 Receptor Function Regulating Agent TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-01-24 US disclosed
US-20080021069-A1 Receptor Function Regulating Agent TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-01-24 US disclosed
EP-1810677-A1 RECEPTOR FUNCTION REGULATING AGENT Takeda Pharmaceutical Company Limited (JP) 2007-07-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080021069-A1 Receptor Function Regulating Agent GPR119, INSR, GPR65 MAPT 4574/4885GAA 3367/4885MEN1 4097/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.